Envoy Medical (Envoy Medical) Accounts Receivable : $0.19 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Envoy Medical Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Envoy Medical's accounts receivables for the quarter that ended in Mar. 2024 was $0.19 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Envoy Medical's Days Sales Outstanding for the quarter that ended in Mar. 2024 was 292.31.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Envoy Medical's Net-Net Working Capital per share for the quarter that ended in Mar. 2024 was $-0.51.

Envoy Medical Accounts Receivable Historical Data

The historical data trend for Envoy Medical's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Envoy Medical Accounts Receivable Chart

Envoy Medical Annual Data

Trend

Dec21

Dec22

Dec23

Accounts Receivable

0.09

0.04

0.07

Envoy Medical Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Receivable	Get a 7-Day Free Trial				-	0.06	0.11	0.07	0.19

Envoy Medical Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Envoy Medical Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Envoy Medical's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.189	/	0.059	*	91
=	292.31

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Envoy Medical's accounts receivable are only considered to be worth 75% of book value:

Envoy Medical's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2024 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(4.945	+	0.75 * 0.189	+	0.5 * 1.455	-	15.893
-	0	-	0)	/	19.6
=	-0.51

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Envoy Medical Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Envoy Medical's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Envoy Medical (Envoy Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Envoy Medical Inc (NAS:COCH) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

4875 White Bear Parkway, White Bear Lake, MN, USA, 55110

Website

https://www.envoymedical.com

Envoy Medical Inc is focused on designing, developing, and marketing fully implantable medical devices that improve hearing. The Company's first commercial product, the Esteem PMA application, is a fully implantable hearing device. The Esteem PMA was cleared in 2010 by the United States Food and Drug Administration. The Company intends to continue to pursue the development of a cochlear implant.